Cargando…

Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death

The tumor necrosis factor-related apoptosis inducing ligand (TRAIL) preferentially induces apoptosis in cancer cells. However, many tumors are resistant to TRAIL-induced apoptosis, and resistance mechanisms are not fully understood. To identify novel regulatory molecules of TRAIL resistance, we scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, So Jung, Jo, Doo Sin, Jo, Se-Young, Shin, Dong Woon, Shim, Sangmi, Jo, Yoon Kyung, Shin, Ji Hyun, Ha, Ye Jin, Jeong, Seong-Yun, Hwang, Jung Jin, Kim, Young Sam, Suh, Young-Ah, Chang, Jong Wook, Kim, Jin Cheon, Cho, Dong-Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323206/
https://www.ncbi.nlm.nih.gov/pubmed/27602754
http://dx.doi.org/10.18632/oncotarget.11781
_version_ 1782509990310838272
author Park, So Jung
Jo, Doo Sin
Jo, Se-Young
Shin, Dong Woon
Shim, Sangmi
Jo, Yoon Kyung
Shin, Ji Hyun
Ha, Ye Jin
Jeong, Seong-Yun
Hwang, Jung Jin
Kim, Young Sam
Suh, Young-Ah
Chang, Jong Wook
Kim, Jin Cheon
Cho, Dong-Hyung
author_facet Park, So Jung
Jo, Doo Sin
Jo, Se-Young
Shin, Dong Woon
Shim, Sangmi
Jo, Yoon Kyung
Shin, Ji Hyun
Ha, Ye Jin
Jeong, Seong-Yun
Hwang, Jung Jin
Kim, Young Sam
Suh, Young-Ah
Chang, Jong Wook
Kim, Jin Cheon
Cho, Dong-Hyung
author_sort Park, So Jung
collection PubMed
description The tumor necrosis factor-related apoptosis inducing ligand (TRAIL) preferentially induces apoptosis in cancer cells. However, many tumors are resistant to TRAIL-induced apoptosis, and resistance mechanisms are not fully understood. To identify novel regulatory molecules of TRAIL resistance, we screened a siRNA library targeting the human kinome, and NEK4 (NIMA-related kinase-4) was identified. Knockdown of NEK4 sensitized TRAIL-resistant cancer cells and in vivo xenografts to cell death. In contrast, over expression of NEK4 suppressed TRAIL-induced cell death in TRAIL-sensitive cancer cells. In addition, loss of NEK4 resulted in decrease of the anti-apoptotic protein survivin, but an increase in apoptotic cell death. Interestingly, NEK4 was highly upregulated in tumor tissues derived from patients with lung cancer and colon cancer. These results suggest that inhibition of NEK4 sensitizes cancer cells to TRAIL-induced apoptosis by regulation of survivin expression.
format Online
Article
Text
id pubmed-5323206
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53232062017-03-23 Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death Park, So Jung Jo, Doo Sin Jo, Se-Young Shin, Dong Woon Shim, Sangmi Jo, Yoon Kyung Shin, Ji Hyun Ha, Ye Jin Jeong, Seong-Yun Hwang, Jung Jin Kim, Young Sam Suh, Young-Ah Chang, Jong Wook Kim, Jin Cheon Cho, Dong-Hyung Oncotarget Research Paper The tumor necrosis factor-related apoptosis inducing ligand (TRAIL) preferentially induces apoptosis in cancer cells. However, many tumors are resistant to TRAIL-induced apoptosis, and resistance mechanisms are not fully understood. To identify novel regulatory molecules of TRAIL resistance, we screened a siRNA library targeting the human kinome, and NEK4 (NIMA-related kinase-4) was identified. Knockdown of NEK4 sensitized TRAIL-resistant cancer cells and in vivo xenografts to cell death. In contrast, over expression of NEK4 suppressed TRAIL-induced cell death in TRAIL-sensitive cancer cells. In addition, loss of NEK4 resulted in decrease of the anti-apoptotic protein survivin, but an increase in apoptotic cell death. Interestingly, NEK4 was highly upregulated in tumor tissues derived from patients with lung cancer and colon cancer. These results suggest that inhibition of NEK4 sensitizes cancer cells to TRAIL-induced apoptosis by regulation of survivin expression. Impact Journals LLC 2016-09-01 /pmc/articles/PMC5323206/ /pubmed/27602754 http://dx.doi.org/10.18632/oncotarget.11781 Text en Copyright: © 2016 Park et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Park, So Jung
Jo, Doo Sin
Jo, Se-Young
Shin, Dong Woon
Shim, Sangmi
Jo, Yoon Kyung
Shin, Ji Hyun
Ha, Ye Jin
Jeong, Seong-Yun
Hwang, Jung Jin
Kim, Young Sam
Suh, Young-Ah
Chang, Jong Wook
Kim, Jin Cheon
Cho, Dong-Hyung
Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title_full Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title_fullStr Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title_full_unstemmed Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title_short Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
title_sort inhibition of never in mitosis a (nima)-related kinase-4 reduces survivin expression and sensitizes cancer cells to trail-induced cell death
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323206/
https://www.ncbi.nlm.nih.gov/pubmed/27602754
http://dx.doi.org/10.18632/oncotarget.11781
work_keys_str_mv AT parksojung inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT jodoosin inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT joseyoung inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT shindongwoon inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT shimsangmi inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT joyoonkyung inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT shinjihyun inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT hayejin inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT jeongseongyun inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT hwangjungjin inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT kimyoungsam inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT suhyoungah inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT changjongwook inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT kimjincheon inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath
AT chodonghyung inhibitionofneverinmitosisanimarelatedkinase4reducessurvivinexpressionandsensitizescancercellstotrailinducedcelldeath